243131-85-3

Upstream product

• 98-59-9 p-toluenesulfonyl chloride 
• 171613-15-3 2,5-anhydro-N-benzyloxycarbonyl-2,5-imino-1,3-O-isopropylidene-D-glucitol 
• 132295-44-4 2,5-anhydro-2,5-imino-D-glucitol 
• 501-53-1 benzyl chloroformate 
• 191851-89-5 2,5-anhydro-N-benzyloxycarbonyl-2,5-imino-D-glucitol 

Downstream Products

• 243131-91-1 2,5-anhydro-N-benzyloxycarbonyl-6-deoxy-6-{[1-(hydroxymethyl)propyl]amino}-2,5-imino-D-glucitol 
• 243131-88-6 2,5-anhydro-N-benzyloxycarbonyl-6-deoxy-6-{[1-(hydroxymethyl)propyl]amino}-2,5-imino-1,3-O-isopropylidene-D-glucitol 
• 243131-87-5 6-amino-2,5-anhydro-2,5-imino-N-benzyloxycarbonyl-1,3-O-isopropylidene-D-glucitol 
• 243131-86-4 2,5-anhydro-6-azido-N-benzyloxycarbonyl-6-deoxy-1,3-O-isopropylidene-2,5-imino-D-glucitol 

Relevant academic research and scientific papers

Ethambutol-sugar hybrids as potential inhibitors of mycobacterial cell-wall biosynthesis

Ethambutol is an established front-line agent for the treatment of tuberculosis, and is also active against Mycobacterium avium infection. However, this agent exhibits toxicity, and is considered to have low potency. The action of ethambutol on the mycoba